Moneycontrol PRO

Buy Ipca Laboratories: target of Rs 2560: Sharekhan

Sharekhan is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 2560 in its research report dated November 09, 2020.

November 11, 2020 / 11:26 AM IST
  • bselive
  • nselive
Todays L/H

Sharekhan's research repor on Ipca Laboratories

Ipca Laboratories Limited (Ipca) clocked strong numbers in Q2FY21 with sales growing 6% y-o-y to Rs 1,361 crore while PAT was up by 38.3% y-o-y to Rs. 267 crore. API segment has immense growth opportunities ahead, as company sees strong demand traction in this segment and is implementing de-bottlenecking to ease out capacity constraints. Formulations segment’s revenues also expected to improve backed by a pick-up in domestic as well as exports markets. Strong earnings prospects, sturdy balance sheet and healthy return ratios bode well.


We retain a Buy on stock with a revised PT of Rs 2,560.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Nov 11, 2020 11:26 am

stay updated

Get Daily News on your Browser
ISO 27001 - BSI Assurance Mark